Tags: neuralink | brain | paralyzed | telekinesis | telepathy | trademark | elon musk

Elon Musk's Neuralink Files to Trademark 'Telepathy'

By    |   Tuesday, 11 March 2025 10:09 PM EDT

Elon Musk's Neuralink filed applications with the U.S. Patent and Trademark Office on March 3 to trademark "Telepathy" and "Telekinesis" as well as other names for future products, Wired reported Wednesday.

The trademark application for the Telepathy application describes an "implantable brain to computer interface for facilitating communication and control of software and hardware," which Forbes reported could be used for aiding people who were paralyzed.

Meanwhile, the Telekinesis filing points to controlling physical objects, such as robotic arms, while "Blindsight," another application, targets vision restoration.

Nick Koutsobinas

Nick Koutsobinas, a Newsmax writer, has years of news reporting experience. A graduate from Missouri State University’s philosophy program, he focuses on exposing corruption and censorship.

© 2025 Newsmax. All rights reserved.


StreetTalk
Elon Musk's Neuralink filed applications with the U.S. Patent and Trademark Office on March 3 to trademark "Telepathy" and "Telekinesis" as well as other names for future products, Wired reported Wednesday.
neuralink, brain, paralyzed, telekinesis, telepathy, trademark, elon musk, blindsight
86
2025-09-11
Tuesday, 11 March 2025 10:09 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Get Newsmax Text Alerts
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved